Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-02-05 Sale |
2021-02-09 7:44 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
1,930 | $215 | $414,950 | 57,227 (Direct) |
View |
2021-02-03 Sale |
2021-02-05 4:52 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
400 | $216.56 | $86,624 | 59,157 (Direct) |
View |
2021-02-03 Sale |
2021-02-05 4:43 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,554 | $213.74 | $332,146 | 70,097 (Indirect Direct) |
View |
2020-11-16 Sale |
2020-11-18 4:16 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
42 | $223.53 | $9,388 | 49,987 (Indirect Direct) |
View |
2020-11-16 Sale |
2020-11-18 4:12 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
91 | $223.53 | $20,341 | 26,838 (Direct) |
View |
2020-11-16 Sale |
2020-11-18 4:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
7 | $223.64 | $1,565 | 35,319 (Indirect Direct) |
View |
2020-11-16 Sale |
2020-11-18 4:10 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
38 | $223.47 | $8,492 | 28,902 (Direct) |
View |
2020-11-10 Purchase |
2020-11-12 08:18 am |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
15,000 | $217.36 | $3,260,465 | 26,210 (Direct) |
View |
2020-11-04 Sale |
2020-11-06 4:09 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
2,330 | $217.74 | $507,329 | 29,168 (Direct) |
View |
2020-11-03 Sale |
2020-11-05 4:16 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $211.92 | $329,115 | 36,873 (Indirect Direct) |
View |
2020-10-05 Sale |
2020-10-07 4:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
10,516 | $266.79 | $2,805,518 | 3,908 (Direct) |
View |
2020-08-06 Sale |
2020-08-10 4:24 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Controller |
1,078 | $271.17 | $292,319 | 23,426 (Indirect Direct) |
View |
2020-08-06 Sale |
2020-08-10 4:22 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
1,223 | $271.2 | $331,672 | 34,176 (Direct) |
View |
2020-08-06 Sale |
2020-08-10 4:19 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
2,073 | $271.2 | $562,205 | 45,326 (Direct) |
View |
2020-08-06 Sale |
2020-08-10 4:13 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,223 | $271.19 | $331,663 | 36,240 (Direct) |
View |
2020-08-03 Sale |
2020-08-05 4:51 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
1,941 | $278.28 | $540,137 | 53,871 (Indirect Direct) |
View |
2020-08-03 Sale |
2020-08-05 4:24 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Controller |
809 | $278.3 | $225,142 | 16,719 (Indirect Direct) |
View |
2020-08-03 Sale |
2020-08-05 4:20 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
2,330 | $278.28 | $648,402 | 31,498 (Direct) |
View |
2020-08-03 Sale |
2020-08-05 4:17 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $278.39 | $432,337 | 38,426 (Indirect Direct) |
View |
2020-08-03 Sale |
2020-08-05 4:14 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,330 | $278.24 | $648,290 | 33,562 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-02-10 Tax Withholding |
2021-02-12 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
2,367 | $214.16 | 33,575 (Direct) |
View |
2021-02-10 Tax Withholding |
2021-02-12 4:04 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
3,101 | $214.16 | 66,996 (Direct) |
View |
2021-02-10 Tax Withholding |
2021-02-12 4:02 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,974 | $214.16 | 58,381 (Direct) |
View |
2021-02-05 Exercise |
2021-02-09 7:44 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
1,930 | $0 | 57,227 (Direct) |
View |
2021-02-05 Exercise |
2021-02-09 7:44 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
1,930 | $86.52 | 57,227 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 5:00 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
21,951 | $0 | 38,138 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:59 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
22,960 | $0 | 35,698 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:57 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Chief Accounting Officer |
11,080 | $0 | 26,181 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:56 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
20,719 | $0 | 41,894 (Direct) |
View |
2020-12-08 Gift |
2021-02-05 4:53 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
3,391 | $0 | 78,673 (Indirect) |
View |
2021-02-03 Option Award |
2021-02-05 4:53 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
32,077 | $0 | 78,673 (Direct) |
View |
2021-02-03 Exercise |
2021-02-05 4:52 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
400 | $0 | 59,157 (Direct) |
View |
2021-02-03 Exercise |
2021-02-05 4:52 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
400 | $86.52 | 59,157 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:52 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
30,389 | $0 | 59,157 (Direct) |
View |
2021-02-03 Tax Withholding |
2021-02-05 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
8,599 | $215.03 | 78,040 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
83,888 | $0 | 78,040 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
44,935 | $0 | 71,583 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:45 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
21,951 | $0 | 35,942 (Direct) |
View |
2021-02-03 Exercise |
2021-02-05 4:43 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,554 | $0 | 70,097 (Direct) |
View |
2021-02-03 Exercise |
2021-02-05 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,554 | $86.52 | 70,097 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
34,778 | $0 | 70,097 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 4:42 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
32,453 | $0 | 61,355 (Direct) |
View |
Ownership |
2021-02-05 4:38 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
0 | $0 | 21,175 (Direct) |
View |
2021-01-15 Option Award |
2021-01-19 4:42 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
194 | $225.99 | 12,823 (Direct) |
View |
2021-01-15 Option Award |
2021-01-19 4:41 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
121 | $225.99 | 260 (Direct) |
View |
2020-11-04 Exercise |
2020-11-06 4:09 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
2,330 | $0 | 29,168 (Direct) |
View |
2020-11-04 Exercise |
2020-11-06 4:09 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
2,330 | $86.52 | 29,168 (Direct) |
View |
2020-11-03 Exercise |
2020-11-05 4:16 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $0 | 36,873 (Direct) |
View |
2020-11-03 Exercise |
2020-11-05 4:16 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $86.52 | 36,873 (Direct) |
View |
2020-10-15 Option Award |
2020-10-19 4:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
196 | $222.81 | 12,629 (Direct) |
View |
2020-10-15 Option Award |
2020-10-19 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
112 | $222.81 | 138 (Direct) |
View |
2020-10-05 Exercise |
2020-10-07 4:11 pm |
N/A 2025-06-03 |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
8,729 | $0 | 3,908 (Direct) |
View |
2020-10-05 Exercise |
2020-10-07 4:11 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
8,729 | $126.68 | 3,908 (Direct) |
View |
2020-08-25 Gift |
2020-08-26 4:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCGLYNN MARGARET G Director |
3,707 | $0 | 877 (Direct) |
View |
2020-08-06 Exercise |
2020-08-10 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Controller |
612 | $155.57 | 23,426 (Direct) |
View |
2020-08-06 Exercise |
2020-08-10 4:24 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Controller |
1,078 | $0 | 23,426 (Direct) |
View |
2020-08-06 Exercise |
2020-08-10 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Controller |
466 | $187.53 | 23,426 (Direct) |
View |
2020-08-06 Exercise |
2020-08-10 4:22 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
1,223 | $155.57 | 34,176 (Direct) |
View |
2020-08-06 Exercise |
2020-08-10 4:22 pm |
N/A 2028-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
1,223 | $0 | 34,176 (Direct) |
View |
2020-08-06 Exercise |
2020-08-10 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
509 | $155.57 | 45,326 (Direct) |
View |
2020-08-06 Exercise |
2020-08-10 4:19 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
2,073 | $0 | 45,326 (Direct) |
View |
2020-08-06 Exercise |
2020-08-10 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
1,564 | $187.53 | 45,326 (Direct) |
View |
2020-08-06 Exercise |
2020-08-10 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,223 | $155.57 | 36,240 (Direct) |
View |
2020-08-06 Exercise |
2020-08-10 4:13 pm |
N/A 2028-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,223 | $0 | 36,240 (Direct) |
View |
2020-08-03 Exercise |
2020-08-05 4:51 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
1,941 | $0 | 53,871 (Direct) |
View |
2020-08-03 Exercise |
2020-08-05 4:51 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
1,941 | $86.52 | 53,871 (Direct) |
View |
2020-08-03 Exercise |
2020-08-05 4:24 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Controller |
809 | $0 | 16,719 (Direct) |
View |
2020-08-03 Exercise |
2020-08-05 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M SVP & Controller |
809 | $86.52 | 16,719 (Direct) |
View |
2020-08-03 Exercise |
2020-08-05 4:20 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
2,330 | $0 | 31,498 (Direct) |
View |
2020-08-03 Exercise |
2020-08-05 4:20 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael EVP, Chief Adm, Leg & BD Off |
2,330 | $86.52 | 31,498 (Direct) |
View |
2020-08-03 Exercise |
2020-08-05 4:17 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $0 | 38,426 (Direct) |
View |
2020-08-03 Exercise |
2020-08-05 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $86.52 | 38,426 (Direct) |
View |
2020-08-03 Exercise |
2020-08-05 4:14 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,330 | $0 | 33,562 (Direct) |
View |
2020-08-03 Exercise |
2020-08-05 4:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,330 | $86.52 | 33,562 (Direct) |
View |
2020-07-15 Option Award |
2020-07-17 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
155 | $292.77 | 12,433 (Direct) |
View |
2020-07-15 Option Award |
2020-07-17 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
26 | $292.77 | 26 (Direct) |
View |